SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-22-001504
Filing Date
2022-11-09
Accepted
2022-11-09 16:06:26
Documents
14
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e618005_8k-arct.htm   iXBRL 8-K 26843
2 e618005_ex99-1.htm EX-99.1 59907
6 GRAPHIC image_001.jpg GRAPHIC 8607
  Complete submission text file 0001193805-22-001504.txt   282754

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE arct-20221109.xsd EX-101.SCH 3233
4 XBRL LABEL FILE arct-20221109_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE arct-20221109_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT e618005_8k-arct_htm.xml XML 3632
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 221372539
SIC: 2834 Pharmaceutical Preparations